Friday 31 March 2017

Espousal of Eco-Friendly Pet Care Products, Customized Services to Boost Demand in Mobile Pet Care Market




"The Report Global Mobile Pet Care Market 2016-2020 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

MarketResearchReports.biz has recently announced the addition of its report, titled “Global Mobile Pet Care Market 2016-2020” to its offering. The report presents insights into key information regarding the chief market catalysts, deterrents, growth opportunities and trends in the global market.

Also called ‘dog sitting’ or ‘cat sitting’, mobile pet care services arrive in a van at one’s doorstep to offer professional grooming services such as a preliminary visual inspection, clipping and trimming of nails, bathing, hair removal, and flea and tick control. Overnight care, walking the pets, and waste cleaning are also offered by these companies. As these firms hire cardio-pulmonary resuscitation (CPR) trained professionals who are apt at administering first aid to pet animals in cases of emergency, pet owners can rely on these services during periods they cannot themselves tend to their pets.

Conventional pet care services that look after several pets at a time cannot be an ideal situation for most pets who might need personal attention and care. As mobile pet care services eliminate stressful situations such as barking of other dogs, aggressive behavior, and restlessness on being placed in enclosures, pet owners have been increasingly preferring these services. As a result of the high convenience of these services, the global market for mobile pet care is slated for substantial growth.

Get Sample Copy Of This Report @

Contrarily, high costs of these treatments might slow down the growth of the global mobile pet care market. However, growth opportunities are in store for the global mobile pet market as more number of mobile pet care services are careful in their selection of products. They are ensuring that eco-friendly, natural, and non-toxic products such as shampoos, oral care products, and wipes are being adopted. For instance, Zoomin Groomin has been using deodorizing and cleaning solutions that are completely non-toxic and eco-friendly. Being anti-bacterial, there is no fear of these products leaving a residue on the sensitive skins of pets. The espousal of sustainable technology aimed at reducing water wastage will also aid the expansion of the market.

Based on geography, Europe, the APAC, North America, and RoW are the key segments of the global market for mobile pet care. Of these, North America emerged as the dominant regional market, and is expected to continue to dominate over the forecast period. Asia Pacific is also slated for considerable expansion, as pets are increasingly being adopted in this region.


Customized services are gaining traction among the customers, and a number of services are striving to diversify their services. Some of the major companies operating in the global market for mobile pet care are Aussie Pet Mobile, The Pooch Mobile, 4 Paws Mobile Spa, Hollywood Grooming, Dial a Dog Wash, My Pet Mobile Vet, Haute Pets, Alpha Grooming Pet Salon, Jungle Pet Spa, The Shot Spot, and Bonkers.

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074

Latest Pharmaceutical and Healthcare Disease Pipeline Guide Duchenne Muscular Dystrophy - Pipeline Review, H1 2017




"The Report Duchenne Muscular Dystrophy - Pipeline Review, H1 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Duchenne Muscular Dystrophy - Pipeline Review, H1 2017, provides an overview of the Duchenne Muscular Dystrophy (Genetic Disorders) pipeline landscape.

Duchenne muscular dystrophy is a condition which causes muscle weakness. DMD is an X-linked disorder. The gene for DMD is present on the X chromosome. It codes for a protein named dystrophin. Dystrophin is essential for providing structural support inside muscle cells. Symptoms usually appear before age 6 and may appear as early as infancy. They include fatigue, learning difficulties, intellectual disability, muscle weakness and progressive difficulty walking.

View Report @

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Duchenne Muscular Dystrophy - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Duchenne Muscular Dystrophy (Genetic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Duchenne Muscular Dystrophy (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Duchenne Muscular Dystrophy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 2, 14, 7, 2, 51, 12 and 1 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 1, 2, 8 and 1 molecules, respectively.

Duchenne Muscular Dystrophy (Genetic Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Get Sample Copy Of This Report @

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Duchenne Muscular Dystrophy (Genetic Disorders).
- The pipeline guide reviews pipeline therapeutics for Duchenne Muscular Dystrophy (Genetic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Duchenne Muscular Dystrophy (Genetic Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Duchenne Muscular Dystrophy (Genetic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Duchenne Muscular Dystrophy (Genetic Disorders)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Duchenne Muscular Dystrophy (Genetic Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Duchenne Muscular Dystrophy (Genetic Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents
Table of Contents 2
Introduction 5
Duchenne Muscular Dystrophy - Overview 6
Duchenne Muscular Dystrophy - Therapeutics Development 7
Duchenne Muscular Dystrophy - Therapeutics Assessment 19
Duchenne Muscular Dystrophy - Companies Involved in Therapeutics Development 29
Duchenne Muscular Dystrophy - Drug Profiles 52
Duchenne Muscular Dystrophy - Dormant Projects 248
Duchenne Muscular Dystrophy - Discontinued Products 251
Duchenne Muscular Dystrophy - Product Development Milestones 252
Appendix 263
About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074

Growing Demand for Advanced Diabetic Gastroparesis - Pipeline Review, H1 2017




"The Report Diabetic Gastroparesis - Pipeline Review, H1 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Gastroparesis - Pipeline Review, H1 2017, provides an overview of the Diabetic Gastroparesis (Gastrointestinal) pipeline landscape.

Gastroparesis is a long-term complication of diabetes that involves the stomach and affects digestion. Prolonged high blood sugar levels can damage nerves in many parts of the body, including the vagus nerve, which controls contractions of the stomach during digestion. Spasms, abdominal pain, feelings of fullness after a small amount of food, and other symptoms such as nausea and vomiting, reflux, heartburn, and bloating are often experienced with gastroparesis. Loss of appetite and reduced absorption of nutrients may also be experienced. Gastroparesis can lead to weight loss and malnutrition.


Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Diabetic Gastroparesis - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Diabetic Gastroparesis (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Diabetic Gastroparesis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Gastroparesis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 3, 3, 1 and 2 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Diabetic Gastroparesis (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Get Sample Copy Of This Report @

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Diabetic Gastroparesis (Gastrointestinal).
- The pipeline guide reviews pipeline therapeutics for Diabetic Gastroparesis (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Diabetic Gastroparesis (Gastrointestinal) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Diabetic Gastroparesis (Gastrointestinal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Diabetic Gastroparesis (Gastrointestinal)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Diabetic Gastroparesis (Gastrointestinal).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Diabetic Gastroparesis (Gastrointestinal) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074

Demand for Cards and Payments in Switzerland to Gain Traction as Consumers Shop More from Overseas Retailers




"The Report The Cards and Payments Industry in Switzerland: Emerging Trends and Opportunities to 2020 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

MarketResearchReports.biz has announced the addition of a report, titled, “The Cards And Payments Industry In Switzerland: Emerging Trends And Opportunities To 2020” to its offering. The 54-page report deals with the recent trends in the cards and payments market of Switzerland. Volumes and values for check payments, credit transfers, direct debits, and payment cards between 2011 and 2015 are also revealed.

The growing popularity of ecommerce is a major catalyst of the market for cards and payments in Switzerland. As more number of Swiss online shoppers buy clothing, shoes, food, and consumer electronics, the market will witness considerable opportunities. Furthermore, a majority of these shoppers use invoice payments, credit card payments, and payments via PayPal. Therefore, the growing use of card payments is likely to have a positive impact on the growth of the market.

The reduction of interchange fees of MasterCard and Visa credit cards is a key trend that is likely to induce growth. Under the new regulation of the Swiss Competition Commission (Comco), the interchange fee has been reduced from 0.95% to 0.75% in August 2015. This fee is expected to be further reduced to 0.44% by August 2017. Although the reduction of interchange fee will benefit card holders, the profitability of card issuers will be reduced.

Another key trend in the Swiss market for cards and payments is the adoption of alternative payment modes such as Sofort and PayPal due to a plethora of available options. Introduction of new payment solutions, a key business strategy of market players, will take the competition among vendors to the next level.

Get Sample Copy Of This Report @

For instance, in February 2017, the WIR Bank launched a new payment service for medium and small enterprises, wherein the card holders can make payments to merchants who are not customers of the WIR Bank. The features of the existing WIRcard and those of the internationally valid Visa V Pay debit card have been combined in this new service. This development is expected to have a significant impact on the market because Swiss consumers are increasingly spending more from foreign ecommerce websites, finds a new study.

The espousal of contactless technology is gaining traction amongst Swiss consumers recently. The findings of the Swiss National Bank suggest that the number of contactless cards in 2015 was 7.1 million. This figure is projected to double by the end of 2020, with greater popularity of contactless cards promoted by card issuers and banks. Almost every major bank in Switzerland has been offering contactless functionality in their payment cards. Retailers such as Coop, Jumbo, Migros, IKEA, and kkiosk have also been accepting payments via contactless cards.


SIX payment Services, 2Checkout, NETbilling, GoCoin, Mondido Payments, PayPal Express Checkout, ePay, QuickPay, WorldPay, MultiSafepay, Checkout.com, and BitPay are some of the major companies operating in the market for cards and payments in Switzerland.

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074

Constant Technological Advancements in Robotic Surgery Facilitate Easy and Precise Navigation for Surgeons



"The Report Global Robotic Surgery Market 2016-2020 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

MarketResearchReports.biz has announced the addition of a new report, titled “Global Robotic Surgery Market 2016-2020”, to its offering. The in-depth study on the global robotic surgery market provides comprehensive insight into the current drivers and restraints, prominent trends and emerging opportunities, product launches of leading players, and strategic dynamics. The research report analyzes the major advances in computer-assisted surgical techniques. The study highlights recent technological advancements in robotic systems and assesses their impact on shaping the competitive landscape in major regions. The research study evaluates revenue share and size of various application and product segments along the forecast period.

The study takes a closer look at the factors boosting the adoption of robotic procedures by surgeons and clinicians across different healthcare settings. The report analyzes the key trends in automation expected to create lucrative opportunities for players in the robot surgery market in major regions such as Asia Pacific, the Americas, and EMEA. The soaring need for minimally invasive surgeries and better surgical outcomes among patients worldwide has stimulated the demand for surgical robots in the healthcare sector. The global robotic surgery market is forecast to expand at an impressive CAGR of 11.34% from 2016 to 2020.

The global robotic surgery market is primarily propelled by the increasing preference for minimally invasive surgeries in various medical specialties such as gynecology, cardiology, oncology, and neurology. The soaring need for reducing hospital stay and facilitating post-surgery recovery has spurred the demand for robotic surgery. The preference for robotic-assisted surgeries over conventional techniques is driven by convenient movement of surgical equipment, less blood loss attributable to precise incision of the affected areas, and significant reduction of post-operative complications. In addition, the application of robotics to gain a high-resolution view of the target areas is expected to propel the robotic surgery market. The rising incidence of various types of cancer and the increasing demand for surgeries from older patients have impelled surgeons to opt for surgical robots to boost patient outcomes. In addition, the robotic-assisted procedures are increasingly being preferred in pelvic surgeries, which require specific dissections and better suturing.
Get Sample Copy Of This Report @

Stringent regulatory requirements by various global agencies such as the U.S. FDA have led to the slow approval of surgical robots, thereby impeding the growth of the market to some extent. However, recent innovations in robotic systems leading to surgical tools with advanced functionalities are expected to open up exciting opportunities for market players to capitalize on. Researchers are relentlessly making efforts to develop robotic systems that can offer surgeons dexterous movement and convenient navigation through the surgical environment.

Leading players are actively forming partnerships with various research institutions and universities to develop high-end surgical robots in order to consolidate their shares in major regions. Major players vying for a sustained share in the global robotic surgery market include Auris Surgical Robotics, Intuitive Surgical, Titan Medical, and Stryker.

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074

Brazil 3PL Market: Government’s Push on Infrastructure Development Stokes Growth



"The Report 3PL Market in Brazil 2016-2020 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

MarketResearchReports.biz has recently added a report, titled, “3PL Market in Brazil 2016-2020,” to its offering. The report throws light on the different aspects of the market for 3PL, short for third-party logistics, to understand its prospects going forward.

A third party logistics company deals with shippers to manage another entity’s logistics department. 3PL primarily entails outsourcing activities associated with logistics and distribution. 3PL service providers manage the supply chain keeping in mind the requirements of customers. They provide strategic and operational value to many shippers across the globe. Companies across different industries are increasing opting for services of 3PL to focus better on their core competencies and make optimal use of available resources.

The 3PL market in the South American country of Brazil is slated to witness sluggish growth in the coming years, predicts the report. The market, currently, is highly fragmented on account the presence of a large number of players that include big multinational, regional, and local vendors. Interestingly, it’s not the well-entrenched global giants but their smaller local counterparts that have intensified the competition in the market with outstanding services.

The smaller and local 3PL companies operating in the market compete primarily on the basis of cost even though they lag the big names in terms of quality, features, and variety of offerings. A noticeable trend in the Brazil 3PL market is vendors increasingly investing in developing new technologies to up their operational efficiencies. Deep-pocketed international players will likely adopt the acquisition route to bolster their positions in the near future.

Get Sample Copy Of this Report @

Driving the 3PL market in Brazil is the steady realization among producers, retailers, and wholesalers about the importance of supply chain management and logistics in helping to gain a competitive advantage. The market also received an impetus from the Logistics Investment Program launched by the government in August 2012 to build, upgrade, and maintain road, waterway, railway, port, and airport infrastructure. Other factors stoking the market are rapid progress in the ecommerce sector and rebound in the manufacturing sector.

Some of the factors hobbling the 3PL market in Brazil are a dearth of proper transportation infrastructure and increase in cargo theft. A few of the noticeable trends in the market are use of multimodal logistics, uptake of eco-friendly vehicles for shipping, and use of new and better technologies.

To present a detailed picture of the current competitive scenario in the Brazil 3PL market, the report studies the top five players in the market, namely CEVA Holdings, DB SCHENKER, Deutsche Post DHL, Kuehne+Nagel, and Nippon Express. It furnishes information on their unique selling points, their various logistics solutions, their revenues, market shares, and possible trajectory in the foreseeable future.

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074

New Report Examines The Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2017



"The Report Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2017, provides an overview of the Alpha- Antitrypsin Deficiency (Genetic Disorders) pipeline landscape.

Alpha-antitrypsin deficiency is an inherited disease that occurs due to lack of alpha-1 antitrypsin (AAT), a protein that protects the lungs. Symptoms include shortness of breath and wheezing, lung infections, rapid heartbeat, weight loss and vision problems. Predisposing factors include smoking, exposure to dust, chemical fumes and infections.

View Report @

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Alpha- Antitrypsin Deficiency (Genetic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Alpha- Antitrypsin Deficiency (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Alpha- Antitrypsin Deficiency and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 3, 1, 9 and 5 respectively. Similarly, the Universities portfolio in Discovery stages comprises 1 molecules, respectively.

Alpha- Antitrypsin Deficiency (Genetic Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Get Sample Copy Of This Report @

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Alpha- Antitrypsin Deficiency (Genetic Disorders).
- The pipeline guide reviews pipeline therapeutics for Alpha- Antitrypsin Deficiency (Genetic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Alpha- Antitrypsin Deficiency (Genetic Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Alpha- Antitrypsin Deficiency (Genetic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Alpha- Antitrypsin Deficiency (Genetic Disorders)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Alpha- Antitrypsin Deficiency (Genetic Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Alpha- Antitrypsin Deficiency (Genetic Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Alpha- Antitrypsin Deficiency - Overview
Alpha- Antitrypsin Deficiency - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Alpha- Antitrypsin Deficiency - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Alpha- Antitrypsin Deficiency - Companies Involved in Therapeutics Development
Adverum Biotechnologies Inc
Alnylam Pharmaceuticals Inc
Apollo Therapeutics LLC
Applied Genetic Technologies Corp
Arrowhead Pharmaceuticals Inc
Carolus Therapeutics Inc
Cevec Pharmaceuticals GmbH
Editas Medicine Inc
Grifols SA
Inhibrx LP
Intellia Therapeutics Inc
International Stem Cell Corp
Ionis Pharmaceuticals Inc
Kamada Ltd
Polyphor Ltd

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074